Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights
              Sponsored by Johnson & Johnson MedTech – Heart Recovery
            
          
          
          Shock
              Other coronary interventions
          Symposium
          
                Johnson & Johnson MedTech
              
                        
                          
                Room 241
              
                      Anchorperson: Alaide Chieffo
Discussants: Mirvat Alasnag, Vasileios Panoulas, Giuseppe Tarantini
Watch this session if you want
- To learn the latest data on Impella in cardiogenic shock
- To learn on how to improve survival of cardiogenic shock patients
- To see latest data and EAPCI consensus on high-risk PCI in patients unsuitable for surgery
Welcome and session objectives
Alaide Chieffo
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction (pPCI)
Mirvat Alasnag
Breaking down cardiogenic shock: an analytical reflection on the DanGer-SHOCK and ECLS-SHOCK trials
Giuseppe Tarantini
One year post DanGer-Shock – Trial insights and subset analysis
Vasileios Panoulas
Session evaluation and key learnings
Alaide Chieffo


















